Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (68 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 14 Dec 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | PGIM India ELSS Tax Saver Fund |
|---|---|
| 14 Dec 2015 | ₹100.00 |
| 03 Nov 2016 | ₹112.29 |
| 24 Sep 2017 | ₹125.77 |
| 16 Aug 2018 | ₹115.88 |
| 07 Jul 2019 | ₹112.29 |
| 27 May 2020 | ₹90.51 |
| 17 Apr 2021 | ₹140.56 |
| 08 Mar 2022 | ₹164.54 |
| 27 Jan 2023 | ₹169.73 |
| 19 Dec 2023 | ₹190.71 |
| 08 Nov 2024 | ₹202.30 |
| 29 Sep 2025 | ₹190.71 |
| 20 Aug 2026 | ₹181.32 |
| Metric | PGIM India · Direct · IDCW NAV ₹18.15 Very High risk ★☆☆☆☆ | Category median ELSS · 68 funds |
|---|---|---|
| -7.40% | +2.22% | |
| +1.36% | +9.76% | |
| +2.59% | +8.88% | |
| +4.86% | +10.68% | |
| +5.73% | +10.64% | |
| +0.29% | — | |
| +7.15% | +11.55% | |
| +8.96% | +12.14% | |
| +5.95% | +10.94% | |
| Risk | ||
| 16.15% | 14.08% | |
| -0.32 | 0.32 | |
| -0.39 | 0.44 | |
| -45.07% | -35.52% | |
| Nifty 500 | — | |
| -9.41% | -1.42% | |
| 0.99 | 0.96 | |
| 67.4% | 91.4% | |
| 111.3% | 94.7% | |
| 1.15% | 1.17% | |
| ₹694.87Cr | ₹694.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 19% | 33% | |
| Vinay Paharia · 3.6y | — | |
| 14 Dec 2015 | — | |
| 92 | — | |
| 36.3% | — | |
| -0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.